Voyager Therapeutics
VYGR
128 hedge funds and large institutions have $206M invested in Voyager Therapeutics in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 18 closing their positions.
8% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 36
6% more call options, than puts
Call options by funds: $272K | Put options by funds: $256K
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
1% more funds holding
Funds holding: 127 → 128 (+1)
5.67% less ownership
Funds ownership: 70.11% → 64.44% (-5.7%)
32% less capital invested
Capital invested by funds: $302M → $206M (-$95.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prudential Financial
Newark,
New Jersey
|
+$2.16M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.12M |
| 3 |
Renaissance Technologies
New York
|
+$1.57M |
| 4 |
Millennium Management
New York
|
+$1.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$6.59M |
| 2 |
State Street
Boston,
Massachusetts
|
-$6.52M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.66M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.37M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.84M |
VYGR Hedge Fund Activity: Q3 2024 in Review
128 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q3 2024, worth a combined $206M — down 32% from $302M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new VYGR positions and 18 closed out — a net gain of 1 holder — while 39 added to existing stakes and 36 trimmed.
The largest buyer was Prudential Financial, adding an estimated $2.16M. The largest seller was American Century Companies, cutting an estimated $6.59M.
- 128 institutional investors held Voyager Therapeutics (VYGR) as of Q3 2024, up from 127 in Q2 2024.
- Funds reported $206M of Voyager Therapeutics stock for Q3 2024, down 32% quarter-over-quarter.
- 19 funds opened new Voyager Therapeutics positions in Q3 2024 and 18 closed out, a net change of +1 holder.
- The largest Voyager Therapeutics buyer in Q3 2024 was Prudential Financial, an estimated $2.16M added.
- The largest Voyager Therapeutics seller in Q3 2024 was American Century Companies, an estimated $6.59M sold.
Based on aggregated 13F filings for Q3 2024.